64
Participants
Start Date
October 28, 2015
Primary Completion Date
November 19, 2020
Study Completion Date
November 19, 2020
Ombitasvir/paritaprevir/ritonavir
Film-coated tablet for oral use
Dasabuvir
Film-coated tablet for oral use
Ribavirin
Film-coated tablet for oral use
Ombitasvir mini tablet
Film-coated tablet for oral use
Paritaprevir mini tablet
Film-coated tablet for oral use
Ritonavir mini tablet
Film-coated tablet for oral use
Dasabuvir mini tablet
Film-coated tablet for oral use
Ribavirin solution
Oral solution
Cliniques Universitaires Saint-Luc /ID# 136910, Brussels
UZ Leuven /ID# 136911, Leuven
Charite Universitaetsmedizin Berlin /ID# 141620, Berlin
Children's Hospital of Philadelphia /ID# 137018, Philadelphia
Hospital Universitario La Paz /ID# 137094, Madrid
University of Florida - Archer /ID# 136830, Gainesville
Advent Health /ID# 167663, Orlando
Helios Klinikum Wuppertal /ID# 142883, Wuppertal
Hospital Universitario y Politecnico La Fe /ID# 137097, Valencia
Indiana University /ID# 137015, Indianapolis
Universitaetsklinikum Freiburg /ID# 141618, Freiburg im Breisgau
Children's Hospital Colorado /ID# 137017, Aurora
UCSF Benioff Childrens Hosp /ID# 136774, San Francisco
Seattle Children's Hospital /ID# 137019, Seattle
Boston Childrens Hospital /ID# 137174, Boston
Boston Medical Center /ID# 136831, Boston
Columbia Univ Medical Center /ID# 136431, New York
Baylor College of Medicine /ID# 136590, Houston
San Jorge Children Hospital /ID# 136832, San Juan
Hospital Sant Joan de Deu /ID# 137096, Esplugues de Llobregat
Hospital Universitario Vall d'Hebron /ID# 137098, Barcelona
Lead Sponsor
AbbVie
INDUSTRY